b12 injections and weight loss for Medical Weight Loss & B12
Description
Many users find that metabolic benefits persist for several weeks after discontinuing treatment, suggesting lasting improvements in cellular function

The compound requires subcutaneous administration for maximum bioavailability, as oral administration results in poor absorption due to first-pass metabolism
Stacking multiple GLP-1 agonists together, such as semaglutide and tirzepatide, is generally not recommended due to overlapping mechanisms and increased side effect risk

The compound could theoretically interact with medications affecting NAD+ metabolism, energy pathways, or the enzymes responsible for its clearance from the body
